UniProt ID | WDR12_HUMAN | |
---|---|---|
UniProt AC | Q9GZL7 | |
Protein Name | Ribosome biogenesis protein WDR12 {ECO:0000255|HAMAP-Rule:MF_03029} | |
Gene Name | WDR12 {ECO:0000255|HAMAP-Rule:MF_03029} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 423 | |
Subcellular Localization | Nucleus, nucleolus . Nucleus, nucleoplasm . | |
Protein Description | Component of the PeBoW complex, which is required for maturation of 28S and 5.8S ribosomal RNAs and formation of the 60S ribosome.. | |
Protein Sequence | MAQLQTRFYTDNKKYAVDDVPFSIPAASEIADLSNIINKLLKDKNEFHKHVEFDFLIKGQFLRMPLDKHMEMENISSEEVVEIEYVEKYTAPQPEQCMFHDDWISSIKGAEEWILTGSYDKTSRIWSLEGKSIMTIVGHTDVVKDVAWVKKDSLSCLLLSASMDQTILLWEWNVERNKVKALHCCRGHAGSVDSIAVDGSGTKFCSGSWDKMLKIWSTVPTDEEDEMEESTNRPRKKQKTEQLGLTRTPIVTLSGHMEAVSSVLWSDAEEICSASWDHTIRVWDVESGSLKSTLTGNKVFNCISYSPLCKRLASGSTDRHIRLWDPRTKDGSLVSLSLTSHTGWVTSVKWSPTHEQQLISGSLDNIVKLWDTRSCKAPLYDLAAHEDKVLSVDWTDTGLLLSGGADNKLYSYRYSPTTSHVGA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAQLQTRFY ------CCCCCCEEE | 20.84 | 19413330 | |
13 | 2-Hydroxyisobutyrylation | TRFYTDNKKYAVDDV CEEECCCCCEECCCC | 50.39 | - | |
14 | Ubiquitination | RFYTDNKKYAVDDVP EEECCCCCEECCCCC | 44.70 | - | |
15 | Phosphorylation | FYTDNKKYAVDDVPF EECCCCCEECCCCCC | 17.29 | 24275569 | |
23 | Phosphorylation | AVDDVPFSIPAASEI ECCCCCCCCCCHHHH | 22.92 | 24275569 | |
63 | Methylation | LIKGQFLRMPLDKHM EECCEEECCCCHHHC | 26.43 | 115919921 | |
121 | Ubiquitination | ILTGSYDKTSRIWSL EEEEECCCCCCEEEE | 39.92 | - | |
121 | Acetylation | ILTGSYDKTSRIWSL EEEEECCCCCCEEEE | 39.92 | 26051181 | |
131 | Ubiquitination | RIWSLEGKSIMTIVG CEEEECCCEEEEEEC | 27.68 | - | |
150 | Acetylation | VKDVAWVKKDSLSCL HCCHHHHCCCCHHHH | 39.91 | 26051181 | |
180 | Ubiquitination | NVERNKVKALHCCRG ECCCCCCEEEEECCC | 47.00 | - | |
191 | Phosphorylation | CCRGHAGSVDSIAVD ECCCCCCCCCEEEEC | 24.43 | 30624053 | |
203 | Ubiquitination | AVDGSGTKFCSGSWD EECCCCCCCCCCCHH | 48.15 | 21890473 | |
203 | Acetylation | AVDGSGTKFCSGSWD EECCCCCCCCCCCHH | 48.15 | 26051181 | |
211 | Acetylation | FCSGSWDKMLKIWST CCCCCHHHHHHHEEE | 39.61 | 26051181 | |
211 | 2-Hydroxyisobutyrylation | FCSGSWDKMLKIWST CCCCCHHHHHHHEEE | 39.61 | - | |
211 | Ubiquitination | FCSGSWDKMLKIWST CCCCCHHHHHHHEEE | 39.61 | - | |
211 | Methylation | FCSGSWDKMLKIWST CCCCCHHHHHHHEEE | 39.61 | 115978705 | |
217 | Phosphorylation | DKMLKIWSTVPTDEE HHHHHHEEECCCCCH | 24.01 | 30266825 | |
218 | Phosphorylation | KMLKIWSTVPTDEED HHHHHEEECCCCCHH | 18.60 | 30266825 | |
221 | Phosphorylation | KIWSTVPTDEEDEME HHEEECCCCCHHHHH | 52.27 | 30266825 | |
230 | Phosphorylation | EEDEMEESTNRPRKK CHHHHHHHCCCCCHH | 20.06 | 28450419 | |
231 | Phosphorylation | EDEMEESTNRPRKKQ HHHHHHHCCCCCHHH | 38.23 | 30108239 | |
239 | Acetylation | NRPRKKQKTEQLGLT CCCCHHHHHHHCCCC | 64.01 | 26051181 | |
239 | Ubiquitination | NRPRKKQKTEQLGLT CCCCHHHHHHHCCCC | 64.01 | - | |
239 | Sumoylation | NRPRKKQKTEQLGLT CCCCHHHHHHHCCCC | 64.01 | 25114211 | |
246 | Phosphorylation | KTEQLGLTRTPIVTL HHHHCCCCCCCEEEE | 30.60 | 25262027 | |
254 | Phosphorylation | RTPIVTLSGHMEAVS CCCEEEECCCHHHHH | 19.79 | - | |
291 | Ubiquitination | DVESGSLKSTLTGNK EECCCCEEEEECCCC | 42.99 | - | |
298 | Acetylation | KSTLTGNKVFNCISY EEEECCCCEEEEEEC | 49.93 | 26051181 | |
304 | Phosphorylation | NKVFNCISYSPLCKR CCEEEEEECCHHHHH | 23.04 | 28152594 | |
305 | Phosphorylation | KVFNCISYSPLCKRL CEEEEEECCHHHHHH | 8.39 | 28152594 | |
306 | Phosphorylation | VFNCISYSPLCKRLA EEEEEECCHHHHHHH | 12.47 | 28152594 | |
310 | Ubiquitination | ISYSPLCKRLASGST EECCHHHHHHHCCCC | 59.12 | - | |
310 | 2-Hydroxyisobutyrylation | ISYSPLCKRLASGST EECCHHHHHHHCCCC | 59.12 | - | |
319 | Methylation | LASGSTDRHIRLWDP HHCCCCCCCEEEECC | 27.50 | 115919917 | |
328 | Phosphorylation | IRLWDPRTKDGSLVS EEEECCCCCCCCEEE | 38.58 | 24719451 | |
337 | Phosphorylation | DGSLVSLSLTSHTGW CCCEEEEEEECCCCC | 23.30 | 24719451 | |
340 | Phosphorylation | LVSLSLTSHTGWVTS EEEEEEECCCCCEEE | 25.09 | 24719451 | |
376 | 2-Hydroxyisobutyrylation | LWDTRSCKAPLYDLA HHCCCCCCCCHHHHH | 55.04 | - | |
376 | Acetylation | LWDTRSCKAPLYDLA HHCCCCCCCCHHHHH | 55.04 | 25953088 | |
376 | Ubiquitination | LWDTRSCKAPLYDLA HHCCCCCCCCHHHHH | 55.04 | - | |
380 | Phosphorylation | RSCKAPLYDLAAHED CCCCCCHHHHHCCCC | 14.09 | 25954137 | |
388 | Ubiquitination | DLAAHEDKVLSVDWT HHHCCCCCEEEEECC | 41.93 | - | |
391 | Phosphorylation | AHEDKVLSVDWTDTG CCCCCEEEEECCCCC | 22.48 | 25954137 | |
397 | Phosphorylation | LSVDWTDTGLLLSGG EEEECCCCCEEEECC | 23.50 | 25954137 | |
411 | Phosphorylation | GADNKLYSYRYSPTT CCCCCEEEEEECCCC | 17.36 | 24719451 | |
412 | Phosphorylation | ADNKLYSYRYSPTTS CCCCEEEEEECCCCC | 10.46 | 23090842 | |
414 | Phosphorylation | NKLYSYRYSPTTSHV CCEEEEEECCCCCCC | 15.69 | 28152594 | |
415 | Phosphorylation | KLYSYRYSPTTSHVG CEEEEEECCCCCCCC | 13.53 | 28152594 | |
417 | Phosphorylation | YSYRYSPTTSHVGA- EEEEECCCCCCCCC- | 34.68 | 30108239 | |
418 | Phosphorylation | SYRYSPTTSHVGA-- EEEECCCCCCCCC-- | 21.88 | 30108239 | |
419 | Phosphorylation | YRYSPTTSHVGA--- EEECCCCCCCCC--- | 20.75 | 30108239 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of WDR12_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of WDR12_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of WDR12_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. |